Ten Largest Investments

Summary by AI ^BETAClose X

JPMorgan Claverhouse Investment Trust PLC has announced its ten largest investments as a percentage of total assets as of October 31, 2025, with HSBC Holdings Plc representing 8.0%, Shell Plc 6.7%, and AstraZeneca Group Plc 5.3%. Other significant holdings include Rolls-Royce Plc at 4.6%, Natwest Group Plc at 4.4%, and Barclays Plc at 3.7%, with GSK Plc and Tesco Plc each at 2.7%, and 3I Group Plc and Rio Tinto Plc both at 2.6%. These top ten investments collectively account for 43.2% of the total assets, excluding liquidity stocks.

Disclaimer*

JPMorgan Claverhouse IT PLC

13 November 2025

JPMORGAN CLAVERHOUSE INVESTMENT TRUST PLC (the 'Company')
Legal Entity Identifier: 549300NFZYYFSCD52W53
THE COMPANY ANNOUNCES THE TEN LARGEST INVESTMENTS IN % OF TOTAL ASSETS As at: 31 October 2025
Hsbc Holdings Plc	8.0%
Shell Plc	6.7%
Astrazeneca Group Plc	5.3%
Rolls-Royce Plc	4.6%
Natwest Group Plc	4.4%
Barclays Plc	3.7%
Gsk Plc	2.7%
Tesco Plc	2.7%
3I Group Plc	2.6%
Rio Tinto Plc	2.6%
Total	43.2%
Excludes Investments in Liquidity stocks
Name of contact and telephone number for queries:
Paul Ainger 0044 207 742 6524
Name of authorised company official responsible for making this notification:
Anmol Dhillon 020 7742 4000 - Company Secretary
Date: 13 November 2025

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END